Hemorrhage Concept

subject area of

• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Journal Articles
• 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants  Journal Articles
• 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis  Journal Articles
• 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Journal Articles
• 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants  Journal Articles
• 2020 International Consensus on First Aid Science With Treatment Recommendations.  Journal Articles
• 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants  Journal Articles
• 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19  Journal Articles
• 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE  Journal Articles
• 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII  Journal Articles
• Reviews: Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis  Journal Articles
• Transfusion practice in the bleeding critically ill: An international online survey—The TRACE‐2 survey  Journal Articles
• d-Dimer Testing to Determine the Duration of Anticoagulation Therapy  Journal Articles
• d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy  Journal Articles
• A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement  Journal Articles
• A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis  Journal Articles
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease  Journal Articles
• A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism  Journal Articles
• A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation  Journal Articles
• A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism  Journal Articles
• A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome  Journal Articles
• A Historical Perspective on the Reversal of Anticoagulants  Journal Articles
• A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke  Journal Articles
• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction  Journal Articles
• A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation  Journal Articles
• A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial  Journal Articles
• A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis  Journal Articles
• A PoTENtial Antidote  Journal Articles
• A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin  Journal Articles
• A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery  Journal Articles
• A Registry-Based Randomized Trial Comparing Radial and Femoral Approaches in Women Undergoing Percutaneous Coronary Intervention  Journal Articles
• A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement  Journal Articles
• A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients  Journal Articles
• A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation  Journal Articles
• A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system  Journal Articles
• A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.  Journal Articles
• A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty  Journal Articles
• A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia  Journal Articles
• A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery  Journal Articles
• A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss  Journal Articles
• A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders  Journal Articles
• A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo  Journal Articles
• A molecular genetic study of factor XI deficiency  Journal Articles
• A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum  Journal Articles
• A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation  Journal Articles
• A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy  Journal Articles
• A new tool to assess bleeding severity in patients with chemotherapy‐induced thrombocytopenia (CME)  Journal Articles
• A new visual indicator of chlamydial cervicitis?  Conferences
• A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment  Journal Articles
• A novel antithrombin-heparin covalent complex  Journal Articles
• A novel endoscopic treatment for ureteric remnant hemorrhage post laparoscopic radical nephrectomy  Journal Articles
• A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation  Journal Articles
• A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.  Journal Articles
• A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban  Journal Articles
• A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes  Journal Articles
• A preliminary application of a haemophilia value framework to emerging therapies in haemophilia  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.  Journal Articles
• A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: Is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples?  Journal Articles
• A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery  Journal Articles
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)  Journal Articles
• A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin  Journal Articles
• A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology  Journal Articles
• A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia  Journal Articles
• A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)  Journal Articles
• A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer  Journal Articles
• A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin  Journal Articles
• A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip  Journal Articles
• A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura  Journal Articles
• A study of the agreement between patient self‐assessment and study personnel assessment of bleeding symptoms  Journal Articles
• A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial  Journal Articles
• A systematic review and meta-analysis of sample size methodology for traumatic hemorrhage trials  Journal Articles
• A systematic review of definitions and reporting of bleeding outcome measures in haemophilia  Journal Articles
• ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery  Journal Articles
• ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease  Journal Articles
• AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging study  Journal Articles
• Abelacimab for Prevention of Venous Thromboembolism  Journal Articles
• Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.  Journal Articles
• Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV  Journal Articles
• Accuracy of a Portable International Normalization Ratio Monitor in Outpatients Receiving Long-Term Oral Anticoagulant Therapy  Journal Articles
• Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals  Journal Articles
• Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years  Journal Articles
• Acquired Hemophilia A  Journal Articles
• Acquired hemophilia masked by warfarin therapy  Journal Articles
• Acral Hemorrhagic Darier’s Disease  Journal Articles
• Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors  Journal Articles
• Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction  Journal Articles
• Activated prothrombin complex concentrate for dabigatran‐associated bleeding  Journal Articles
• Acute management of bleeding in patients on novel oral anticoagulants  Journal Articles
• Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants  Journal Articles
• Acute reversal of anticoagulant-induced bleeding complications.  Journal Articles
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation  Journal Articles
• Additional Events in the RE-LY Trial  Journal Articles
• Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia  Journal Articles
• Adherence to anticoagulant treatment with dabigatran in a real‐world setting  Journal Articles
• Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study  Journal Articles
• Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges  Journal Articles
• Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness  Journal Articles
• Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis  Journal Articles
• Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis  Journal Articles
• Adjusted dose continuous infusion of factor VIII in patients with haemophilia A  Journal Articles
• Adults with first-time nephrotic syndrome had increased risk for thromboembolic events, higher near time of diagnosis  Journal Articles
• Advances in Antithrombotic Therapy: Novel Agents  Journal Articles
• Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes  Journal Articles
• Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study  Journal Articles
• After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy  Journal Articles
• After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding  Journal Articles
• Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial  Journal Articles
• Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation  Journal Articles
• Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper  Journal Articles
• Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.  Journal Articles
• Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS)  Journal Articles
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction  Journal Articles
• An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1  Journal Articles
• An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: A meta-analysis of contemporary randomized controlled trials  Journal Articles
• An open clinical study assessing the efficacy and safety of Factor IX Grifols, a high-purity Factor IX concentrate, in patients with severe haemophilia B.  Journal Articles
• An overview of clinical trials of low molecular weight heparin fractions.  Journal Articles
• An unusual presentation of neonatal adrenal hemorrhage  Journal Articles
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation  Journal Articles
• Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study  Journal Articles
• Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors  Journal Articles
• Andexanet Alfa for Reversal of Factor Xa Inhibitors: A Critical Review of the Evidence  Journal Articles
• Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban  Journal Articles
• Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity  Journal Articles
• Andexanet alfa for the treatment of hemorrhage  Journal Articles
• Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis  Journal Articles
• Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial  Journal Articles
• Anemia-Induced Bleeding in Patients with Platelet Disorders  Journal Articles
• Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial  Journal Articles
• Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?  Journal Articles
• Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis  Journal Articles
• Anticoagulant therapy after acute myocardial infarction  Journal Articles
• Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis  Journal Articles
• Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis  Journal Articles
• Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease  Journal Articles
• Anticoagulants in heart disease: current status and perspectives  Journal Articles
• Anticoagulants in pregnancy: A review of indications and complications  Journal Articles
• Anticoagulation Therapy in Children  Journal Articles
• Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials.  Journal Articles
• Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group  Journal Articles
• Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target  Journal Articles
• Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding  Journal Articles
• Anticoagulation for perioperative thromboprophylaxis in people with cancer  Journal Articles
• Anticoagulation for prosthetic heart valves  Journal Articles
• Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.  Journal Articles
• Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion  Journal Articles
• Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada  Journal Articles
• Anticoagulation use in perioperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis  Journal Articles
• Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial  Journal Articles
• Antidotes for Novel Oral Anticoagulants  Journal Articles
• Antiphospholipid antibody syndrome  Journal Articles
• Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke  Journal Articles
• Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention  Journal Articles
• Antiplatelet Therapy versus Anticoagulation after Surgical Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis  Journal Articles
• Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials  Journal Articles
• Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair  Journal Articles
• Antithrombotic Agents  Journal Articles
• Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation  Journal Articles
• Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation  Journal Articles
• Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Antithrombotic Therapy for Atrial Fibrillation  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making  Journal Articles
• Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses  Journal Articles
• Antithrombotic and bleeding effects of glycosaminoglycans with different degrees of sulphation  Journal Articles
• Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding  Journal Articles
• Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation  Journal Articles
• Antithrombotic therapy in atrial fibrillation.  Journal Articles
• Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation  Journal Articles
• Antithrombotics in stable peripheral artery disease  Journal Articles
• Apixaban for Extended Treatment of Venous Thromboembolism  Journal Articles
• Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation  Journal Articles
• Apixaban in Acute Coronary Syndromes  Journal Articles
• Apixaban in Patients with Atrial Fibrillation  Journal Articles
• Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy  Journal Articles
• Apixaban to Prevent Venous Thromboembolism in Patients with Cancer  Journal Articles
• Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement  Journal Articles
• Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients  Journal Articles
• Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation  Journal Articles
• Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk: A population-based cohort study.  Journal Articles
• Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome  Journal Articles
• Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Journal Articles
• Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.  Journal Articles
• Approaches to Diagnosing and Managing Anticoagulant-Related Bleeding  Journal Articles
• Approaches to investigating common bleeding disorders: An evaluation of North American coagulation laboratory practices  Journal Articles
• Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery  Journal Articles
• Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement  Journal Articles
• Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials  Journal Articles
• Are older patients with mechanical heart valves at increased risk?  Journal Articles
• Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia  Journal Articles
• Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia  Journal Articles
• Arrested blood flow during false aneurysm formation in the carotid arteries of cattle slaughtered with and without stunning.  Journal Articles
• Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis  Journal Articles
• Aspiration thrombectomy prior to percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis  Journal Articles
• Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty  Journal Articles
• Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke  Journal Articles
• Aspirin for the Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery  Journal Articles
• Aspirin in coronary artery surgery: 1-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery trial  Journal Articles
• Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty  Journal Articles
• Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding  Journal Articles
• Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants  Journal Articles
• Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin  Journal Articles
• Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta‐analysis of randomized controlled trials  Journal Articles
• Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH  Journal Articles
• Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation  Journal Articles
• Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events  Journal Articles
• Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials  Journal Articles
• Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis  Journal Articles
• Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment—A nationwide register‐based study  Journal Articles
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation  Journal Articles
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism  Journal Articles
• Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation  Journal Articles
• Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase  Journal Articles
• BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study  Journal Articles
• BAY 81-8973 Demonstrates Long-Term Safety and Efficacy in Children With Severe Haemophilia A: Results From the LEOPOLD Kids Extension Study.  Journal Articles
• BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial  Journal Articles
• Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach  Journal Articles
• Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation  Journal Articles
• Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey  Journal Articles
• Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: A survey of healthcare professionals  Journal Articles
• Baseline Risks of Venous Thromboembolism and Major Bleeding are Crucial in Decision-making on Thromboprophylaxis  Journal Articles
• Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT)  Journal Articles
• Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial  Journal Articles
• Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups  Journal Articles
• Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty  Journal Articles
• Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia  Journal Articles
• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome  Journal Articles
• Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials  Journal Articles
• Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness  Journal Articles
• Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)  Journal Articles
• Beyond Unfractionated Heparin and Warfarin  Journal Articles
• Bivalirudin  Journal Articles
• Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients with Non‐ST‐Segment Elevation Acute Coronary Syndrome Initially Treated with Fondaparinux: Results from an International, Multicenter, Randomized Pilot Study (SWITCH III)  Journal Articles
• Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation  Journal Articles
• Bleeding Complications and Management on anticoagulant therapy  Journal Articles
• Bleeding Complications in Acute Coronary Syndromes and Percutaneous Coronary Intervention: Predictors, Prognostic Significance, and Paradigms for Reducing Risk  Journal Articles
• Bleeding Complications in Patients with Acute Coronary Syndromes: Are They Important and How Can We Prevent Them?  Journal Articles
• Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials  Journal Articles
• Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis  Journal Articles
• Bleeding Risks With Non-Vitamin K Oral Anticoagulants Versus Single Antiplatelet Therapy : A Systematic Review and Meta-analysis of Randomized Trials.  Journal Articles
• Bleeding and antidotes in new oral anticoagulants  Journal Articles
• Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes  Journal Articles
• Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing  Journal Articles
• Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry  Journal Articles
• Bleeding and thrombotic problems in a patient with alpha2 plasmin inhibitor deficiency  Journal Articles
• Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency  Journal Articles
• Bleeding associated with antithrombotic therapy.  Journal Articles
• Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk.  Journal Articles
• Bleeding complications in immune thrombocytopenia  Journal Articles
• Bleeding during critical illness: A prospective cohort study using a new measurement tool  Journal Articles
• Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review  Journal Articles
• Bleeding events with dabigatran or warfarin in patients with venous thromboembolism  Journal Articles
• Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology  Journal Articles
• Bleeding in patients with renal insufficiency: A practical guide to clinical management  Journal Articles
• Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation  Journal Articles
• Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents  Journal Articles
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Journal Articles
• Bleeding risks associated with inheritance of the Quebec platelet disorder  Journal Articles
• Bleeding risks associated with vitamin K antagonists  Journal Articles
• Bleeding self‐assessments by patients with immune thrombocytopenia (ITP): An agreement study  Journal Articles
• Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience  Journal Articles
• Bleeding with direct oral anticoagulants vs warfarin: clinical experience  Journal Articles
• Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures  Journal Articles
• Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study  Journal Articles
• Bone marrow biopsy morbidity and mortality: 2002 data.  Journal Articles
• Bridge Therapy Outcomes in Patients With Mechanical Heart Valves  Journal Articles
• Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery  Journal Articles
• Bridging therapy in patients on long‐term oral anticoagulants who require surgery: the Prospective Peri‐operative Enoxaparin Cohort Trial (PROSPECT)  Journal Articles
• Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin  Journal Articles
• Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation  Journal Articles
• Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders  Journal Articles
• Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age?  Journal Articles
• Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada  Journal Articles
• Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE  Journal Articles
• Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants  Journal Articles
• Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial)  Journal Articles
• Cardioversion of Atrial Fibrillation in ENGAGE AF‐TIMI 48  Journal Articles
• Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention  Journal Articles
• Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS  Journal Articles
• Central nervous system bleeding in patients with rare bleeding disorders  Journal Articles
• Certainty ranges facilitated explicit and transparent judgments regarding evidence credibility  Journal Articles
• Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial  Journal Articles
• Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials  Journal Articles
• Circulating heparin‐like anticoagulants: Case report and review of literature  Journal Articles
• Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism  Journal Articles
• Clinical Experience with Anticoagulant Therapy During Pregnancy  Journal Articles
• Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study  Journal Articles
• Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism  Journal Articles
• Clinical Implications of Reversal Agents for Direct Oral Anticoagulants  Journal Articles
• Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry  Journal Articles
• Clinical Relevance of Bleeding Index  Journal Articles
• Clinical Use of Low Molecular Weight Heparins and Heparinoids  Journal Articles
• Clinical and pathological findings in dogs following supralethal total body irradiation with and without infusion of autologous long-term marrow culture cells.  Journal Articles
• Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis  Journal Articles
• Clinical impact of neonatal thrombocytopenia  Journal Articles
• Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin  Journal Articles
• Clinical profile of patients with systemic autoimmune diseases treated in the intensive care unit who developed diffuse alveolar haemorrhage – an observational retrospective cohort study  Journal Articles
• Clinical relevance of bleeding index - In reply  Journal Articles
• Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications  Journal Articles
• Clinical trials evaluating pathogen‐reduced platelet products: methodologic issues and recommendations  Journal Articles
• Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events  Journal Articles
• Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis  Journal Articles
• Closure of a Percutaneous Endoscopic Gastrostomy-Associated Nonhealing Gastrocutaneous Fistula Using Endoscopic Hemoclips  Journal Articles
• Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass  Journal Articles
• Coagulopathy related to dilution and hypotension during massive transfusion  Journal Articles
• Cochrane in CORR ®: Topical Application of Tranexamic Acid for the Reduction of Bleeding (Review)  Journal Articles
• Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease  Journal Articles
• Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis  Journal Articles
• Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study  Journal Articles
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol  Journal Articles
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study  Journal Articles
• Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?  Journal Articles
• Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE  Journal Articles
• Comparative effects of heparin and LMW heparin on hemostasis  Conferences
• Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes  Journal Articles
• Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study  Journal Articles
• Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry  Journal Articles
• Comparing bleed frequency and factor concentrate use between haemophilia A and B patients  Journal Articles
• Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials  Journal Articles
• Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis  Conferences
• Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor  Journal Articles
• Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin  Journal Articles
• Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy  Journal Articles
• Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes  Journal Articles
• Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral Anticoagulant  Journal Articles
• Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction  Journal Articles
• Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention.  Journal Articles
• Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women  Journal Articles
• Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial  Journal Articles
• Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial  Journal Articles
• Comparison of longitudinal leukocyte gene expression after burn injury or trauma-hemorrhage in mice  Journal Articles
• Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial  Journal Articles
• Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models  Journal Articles
• Comparison of the haemorrhagic effects of porcine and bovine heparin in rabbits  Journal Articles
• Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction  Journal Articles
• Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers  Journal Articles
• Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II  Journal Articles
• Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial.  Journal Articles
• Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial  Journal Articles
• Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting  Journal Articles
• Continuous intravenous infusion of a plasma‐derived factor IX concentrate (Mononine^®) in haemophilia B  Journal Articles
• Control of Severe, Life-Threatening External Bleeding in the Out-of-Hospital Setting: A Systematic Review  Journal Articles
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Journal Articles
• Costs of on‐demand and prophylactic treatment for severe haemophilia in Norway and Sweden  Journal Articles
• Cost‐utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada  Journal Articles
• Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics  Journal Articles
• Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura  Journal Articles
• D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders  Journal Articles
• DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines  Journal Articles
• Dabigatran Etexilate: Future Directions in Anticoagulant Treatment  Journal Articles
• Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery  Journal Articles
• Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment  Journal Articles
• Dabigatran Versus Warfarin in Patients With Atrial Fibrillation  Journal Articles
• Dabigatran etexilate for prevention of venous thromboembolism  Journal Articles
• Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial  Journal Articles
• Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation  Journal Articles
• Dabigatran monitoring made simple?  Journal Articles
• Dabigatran reversal by idarucizumab in the setting of intracranial hemorrhage: A systematic review of the literature  Journal Articles
• Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II  Journal Articles
• Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.  Journal Articles
• Dabigatran versus Warfarin in Patients with Atrial Fibrillation  Journal Articles
• Dabigatran versus Warfarin in Patients with Mechanical Heart Valves  Journal Articles
• Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer  Journal Articles
• Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency  Journal Articles
• Dalteparin versus Unfractionated Heparin in Critically Ill Patients  Journal Articles
• Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)  Journal Articles
• Death of a Child From Topical Diphenhydramine  Journal Articles
• Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009)  Journal Articles
• Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk  Journal Articles
• Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology  Journal Articles
• Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH  Journal Articles
• Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation  Journal Articles
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients  Journal Articles
• Definition of major bleeding used by US anticoagulation clinics  Journal Articles
• Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department  Journal Articles
• Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran  Journal Articles
• Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy  Journal Articles
• Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy  Journal Articles
• Determinants of Bleeding Risk in Patients on Antithrombotic and Antifibrinolytic Drugs  Journal Articles
• Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog.  Journal Articles
• Diagnosis and Management of Mild Bleeding Disorders  Journal Articles
• Diagnosis and Management of Neonatal Alloimmune Thrombocytopenia  Journal Articles
• Diagnosis of DVT  Journal Articles
• Diagnostic Yield and Complication Rate in Percutaneous Needle Biopsy of Renal Hilar Masses With Comparison With Renal Cortical Mass Biopsies in a Cohort of 195 Patients  Journal Articles
• Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice  Journal Articles
• Differences in the safety profiles of two low-molecular-weight heparins  Journal Articles
• Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis  Journal Articles
• Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation  Journal Articles
• Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding  Journal Articles
• Direct Oral Anticoagulants  Journal Articles
• Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis  Journal Articles
• Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials  Journal Articles
• Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study  Journal Articles
• Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies  Journal Articles
• Direct oral anticoagulant dose selection: Challenging cases  Journal Articles
• Direct oral anticoagulants after bariatric surgery—What is the evidence?  Journal Articles
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials  Journal Articles
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.  Journal Articles
• Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis  Journal Articles
• Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysis  Journal Articles
• Direct oral anticoagulants: a practical guide for the emergency physician  Journal Articles
• Direct oral anticoagulants: evidence and unresolved issues  Journal Articles
• Direct thrombin inhibitors in cardiovascular disease  Journal Articles
• Discontinuation rates of intrauterine contraception due to unfavourable bleeding: a systematic review  Journal Articles
• Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?  Journal Articles
• Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin?  Journal Articles
• Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes  Journal Articles
• Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement  Journal Articles
• Dose–response study of recombinant human soluble thrombomodulin (ART‐123) in the prevention of venous thromboembolism after total hip replacement  Journal Articles
• Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary Syndrome  Journal Articles
• Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention  Journal Articles
• Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review  Journal Articles
• Dual Antiplatelet Therapy After Percutaneous Coronary Intervention  Journal Articles
• Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence  Journal Articles
• Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society  Journal Articles
• Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH  Journal Articles
• Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia  Journal Articles
• Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism  Journal Articles
• Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.  Journal Articles
• Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis.  Journal Articles
• Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation  Journal Articles
• Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes  Journal Articles
• Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy  Journal Articles
• Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves  Journal Articles
• Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism  Journal Articles
• Edoxaban for treatment of venous thromboembolism in patients with cancer  Journal Articles
• Edoxaban versus Warfarin in Patients with Atrial Fibrillation  Journal Articles
• Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial  Journal Articles
• Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A  Journal Articles
• Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism  Journal Articles
• Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation  Journal Articles
• Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty  Journal Articles
• Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA Registry  Journal Articles
• Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis  Journal Articles
• Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure  Journal Articles
• Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events  Journal Articles
• Effectiveness and safety of abciximab after failed thrombolytic therapy  Journal Articles
• Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min  Journal Articles
• Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism  Journal Articles
• Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism  Journal Articles
• Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1  Journal Articles
• Effectiveness of Anticoagulants  Journal Articles
• Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction11Guest Editor for this manuscript was Peter B. Berger, MD, Mayo Clinic, Rochester, Minn.  Journal Articles
• Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes  Journal Articles
• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation  Journal Articles
• Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial  Journal Articles
• Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation  Journal Articles
• Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study  Journal Articles
• Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding  Journal Articles
• Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.  Journal Articles
• Effects of changes in topographical distribution of lung blood flow on gas exchange  Journal Articles
• Effects of dabigatran according to age in atrial fibrillation  Journal Articles
• Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment  Journal Articles
• Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial  Journal Articles
• Effects of sodium warfarin administered during pregnancy in mice  Journal Articles
• Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial.  Journal Articles
• Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial  Journal Articles
• Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment  Journal Articles
• Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials  Journal Articles
• Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: comment  Journal Articles
• Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial -  Journal Articles
• Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism  Journal Articles
• Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation  Journal Articles
• Efficacy and Safety of the Factor VIII/von Willebrand Factor Concentrate, Haemate-P/Humate-P: Ristocetin Cofactor Unit Dosing in Patients with von Willebrand Disease  Journal Articles
• Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial  Journal Articles
• Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial  Journal Articles
• Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial  Journal Articles
• Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement  Journal Articles
• Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial  Journal Articles
• Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves  Journal Articles
• Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease  Journal Articles
• Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD  Journal Articles
• Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis  Journal Articles
• Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER^®, RE-COVER™ II, and RE-MEDY™  Journal Articles
• Efficacy of high dose tranexamic acid (TXA) for hemorrhage: A systematic review and meta-analysis  Journal Articles
• Electron microscopy examination of platelet whole mount preparations to quantitate platelet dense granule numbers: Implications for diagnosing suspected platelet function disorders due to dense granule deficiency  Journal Articles
• Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants  Journal Articles
• Endpoint adjudication in cardiovascular clinical trials  Journal Articles
• Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction  Journal Articles
• Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years  Journal Articles
• Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty  Journal Articles
• Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction  Journal Articles
• Establishing an Optimal Therapeutic Range for Coumarins  Journal Articles
• Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial  Journal Articles
• Ethnoracial variations in venous thrombosis: Implications for management, and a call to action  Journal Articles
• Evaluating Hemorrhage in Renal Cell Carcinoma Using Susceptibility Weighted Imaging  Journal Articles
• Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants  Journal Articles
• Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis  Journal Articles
• Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat  Journal Articles
• Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation  Journal Articles
• Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor  Journal Articles
• Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas  Journal Articles
• Evaluation of the utility of the ISTH‐BAT in haemophilia carriers: a multinational study  Journal Articles
• Evidence-Based Management of Anticoagulant Therapy  Journal Articles
• Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controls.  Journal Articles
• Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolism  Journal Articles
• Experiences with continuous infusion of recombinant activated factor VII.  Conferences
• Expert Approaches to Common Bleeding and Thrombotic Problems, Part II  Journal Articles
• Expert Approaches to Common Bleeding and Thrombotic Problems—Part I  Journal Articles
• Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy  Journal Articles
• Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients  Journal Articles
• Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism  Journal Articles
• Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study  Journal Articles
• Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study  Journal Articles
• Extended perioperative thromboprophylaxis in patients with cancer  Journal Articles
• Extended perioperative thromboprophylaxis in patients with cancer. A systematic review.  Journal Articles
• Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study  Journal Articles
• Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility  Journal Articles
• Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials  Journal Articles
• Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.  Journal Articles
• Extension of anticoagulation after venous thromboembolism  Journal Articles
• FEASIBILITY AND SAFETY OF FULL DOSE ANTICOAGULATION THERAPY (ACT) IN CHILDREN TREATED ACCORDING TO DANA-FARBER CANCER INSTITUTE (DFCI) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CONSORTIUM THERAPY PROTOCOLS  Conferences
• FRAIL-AF Study: More Bleeding With DOACs Compared With VKAs in Patients With Frailty?  Journal Articles
• Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials  Journal Articles
• Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene  Journal Articles
• Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis  Journal Articles
• Factor XI Inhibitors: Potential Role in End-Stage Kidney Disease  Journal Articles
• Factor XI inhibition in cardiovascular disease  Journal Articles
• Factor XI inhibitors: cardiovascular perspectives  Journal Articles
• Factor XI inhibitors: what should clinicians know  Journal Articles
• Factor XIa inhibition as a therapeutic strategy for atherothrombosis  Journal Articles
• Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial  Journal Articles
• Factors Associated With Adverse Outcomes in Outpatients Presenting With Pulmonary Embolism  Journal Articles
• Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia  Journal Articles
• Factors at Admission Associated With Bleeding Risk in Medical Patients  Journal Articles
• Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records  Journal Articles
• Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review  Journal Articles
• Feasibility and safety of delivering full‐dose anticoagulation therapy in children treated according to Dana‐Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols  Journal Articles
• Fetal Effects of Coumadin Administered During Pregnancy  Journal Articles
• Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors  Journal Articles
• First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study  Journal Articles
• First-Line Therapy for Immune Thrombocytopenia  Journal Articles
• Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty  Journal Articles
• Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysis  Journal Articles
• Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control  Journal Articles
• Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Journal Articles
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery  Journal Articles
• Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery  Journal Articles
• Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk  Journal Articles
• Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs  Journal Articles
• Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study  Journal Articles
• Fondaparinux in the management of patients with ST-elevation acute myocardial infarction  Journal Articles
• Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6  Journal Articles
• Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin  Journal Articles
• Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding  Journal Articles
• Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors  Journal Articles
• Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants  Journal Articles
• Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source  Journal Articles
• Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors  Journal Articles
• G-Protein–Coupled Receptors as Signaling Targets for Antiplatelet Therapy  Journal Articles
• GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation  Journal Articles
• Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.  Journal Articles
• Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding  Journal Articles
• Genetic Determinants of Warfarin Maintenance Dose and Time in Therapeutic Treatment Range: A RE-LY Genomics Substudy  Journal Articles
• Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation  Journal Articles
• Global Prospective Safety Analysis of Rivaroxaban  Journal Articles
• Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial  Journal Articles
• Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors  Journal Articles
• Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation  Journal Articles
• Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.  Journal Articles
• Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations  Journal Articles
• HEMORRHAGIC COMPLICATIONS OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL-INFARCTION AND VENOUS THROMBOEMBOLISM  Journal Articles
• HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS  Journal Articles
• Haemophilia Experiences, Results and Opportunities (HERO) study: treatment‐related characteristics of the population  Journal Articles
• Haemophilia prophylaxis: how can we justify the costs?  Journal Articles
• Haemorrhagic and Thromboembolic Complications versus Intensity of Treatment of Venous Thromboembolism with Oral Anticoagulants  Journal Articles
• Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants.  Journal Articles
• Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin  Journal Articles
• Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1  Journal Articles
• Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study  Journal Articles
• Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding  Journal Articles
• Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study  Journal Articles
• Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review  Journal Articles
• Hemorrhage After Auricular Acupuncture due to Postoperative Dilutional Thrombocytopenia  Journal Articles
• Hemorrhagic Complications Following Abdominal Paracentesis in Acute on Chronic Liver Failure: A Propensity Score Analysis.  Journal Articles
• Hemorrhagic Complications in Pediatric Hematologic Malignancies  Journal Articles
• Hemorrhagic Complications of Anticoagulant Therapy  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment  Journal Articles
• Hemorrhagic Complications of Long-term Anticoagulant Therapy  Journal Articles
• Hemorrhagic Complications of Long-term Anticoagulant Therapy  Journal Articles
• Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism  Conferences
• Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism  Journal Articles
• Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism  Journal Articles
• Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated?  Journal Articles
• Hemorrhagic complications of anticoagulant treatment.  Journal Articles
• Hemorrhagic complications of anticoagulant treatment.  Journal Articles
• Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.  Journal Articles
• Hemorrhagic complications of long-term anticoagulant therapy.  Journal Articles
• Hemorrhagic complications of long-term anticoagulant therapy.  Journal Articles
• Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.  Journal Articles
• Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.  Journal Articles
• Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect  Journal Articles
• Heparin and Graduated Compression Stockings in Patients  Journal Articles
• Heparin and Low-Molecular-Weight Heparin  Journal Articles
• Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis  Journal Articles
• Heparin induced bleeding.  Journal Articles
• Heparin-Induced Thrombocytopenia Presenting as Bilateral Adrenal Hemorrhages  Journal Articles
• Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety  Journal Articles
• Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.  Journal Articles
• Hepatic Interstitial Laser Photocoagulation An Investigation of the Relationship between Acute Thermal Lesions and their Sonographic Images  Journal Articles
• High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice  Journal Articles
• Hirudin and thrombosis prophylaxis  Journal Articles
• Home-monitoring of oral anticoagulation vs. dabigatran  Journal Articles
• Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone  Journal Articles
• How Did We Get Here?: A Historical Review and Critical Analysis of Anticoagulation Therapy Following Mechanical Valve Replacement  Journal Articles
• How I investigate for bleeding disorders  Journal Articles
• How I treat target-specific oral anticoagulant–associated bleeding  Journal Articles
• How can we reverse bleeding in patients on direct oral anticoagulants?  Journal Articles
• How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.  Conferences
• How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society  Journal Articles
• How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice  Journal Articles
• INVIVO EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARINS ON EXPERIMENTAL THROMBOSIS AND BLEEDING  Journal Articles
• ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders  Journal Articles
• Iatrogenic Adverse Events in the Coronary Care Unit  Journal Articles
• Idarucizumab  Journal Articles
• Idarucizumab for Dabigatran Reversal  Journal Articles
• Idarucizumab for Dabigatran Reversal — Full Cohort Analysis  Journal Articles
• Identified unmet needs and proposed solutions in mild‐to‐moderate haemophilia: A summary of opinions from a roundtable of haemophilia experts  Journal Articles
• Identifying the highest risk vascular patients: Insights from the XATOA registry  Journal Articles
• Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]  Journal Articles
• Imaging of stroke: a comparison between X-ray fluorescence and magnetic resonance imaging methods  Journal Articles
• Immune thrombocytopenia (ITP) World Impact Survey (I‐WISh): Impact of ITP on health‐related quality of life  Journal Articles
• Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding  Journal Articles
• Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting  Journal Articles
• Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease  Journal Articles
• Impact of Intraoperative Arteriography on Limb Salvage for Traumatic Popliteal Artery Injury  Journal Articles
• Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban  Journal Articles
• Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial  Journal Articles
• Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients  Journal Articles
• Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial  Journal Articles
• Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction  Journal Articles
• Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement  Journal Articles
• Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes  Journal Articles
• Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts  Journal Articles
• Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation  Journal Articles
• Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes  Journal Articles
• In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding  Journal Articles
• In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulants  Journal Articles
• In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets  Journal Articles
• In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS₂and CHA₂DS₂-VASc  Journal Articles
• In medical inpatients, the IMPROVE risk score had moderate predictive power for 14-d in-hospital bleeding  Journal Articles
• In patients receiving DAPT after coronary stents, the PRECISE-DAPT score predicted bleeding moderately well  Journal Articles
• In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding  Journal Articles
• In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding  Journal Articles
• Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy  Journal Articles
• Incidence and predictors of splanchnic vein thrombosis and mortality following hepatobiliary and pancreatic surgery  Journal Articles
• Indirect comparisons of efficacy and weekly factor consumption during continuous prophylaxis with recombinant factor VIII Fc fusion protein and conventional recombinant factor VIII products  Journal Articles
• Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation  Journal Articles
• Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC‐AF risk scores  Journal Articles
• Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention  Journal Articles
• Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates  Journal Articles
• Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE  Journal Articles
• Influence of low-intensity warfarin treatment on patients' perceptions of quality of life  Journal Articles
• Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome  Journal Articles
• Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta‐analysis  Journal Articles
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction  Journal Articles
• Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis  Journal Articles
• International Normalized Ratio Targets for Left-Sided Mechanical Valve Replacement  Journal Articles
• International assessment of massive transfusion protocol contents and indications for activation  Journal Articles
• Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy  Journal Articles
• Intracranial hemorrhage in patients treated for SARS-CoV-2 with extracorporeal membrane oxygenation: A systematic review and meta-analysis  Journal Articles
• Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice  Journal Articles
• Is aspirin safer than a direct oral anticoagulant for patients with atrial fibrillation at high risk of bleeding?  Journal Articles
• Is there really misuse and abuse of dabigatran?  Journal Articles
• Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48  Journal Articles
• Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy  Journal Articles
• Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation  Journal Articles
• Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study  Journal Articles
• LMW Heparin for Deep Vein Thrombosis  Journal Articles
• Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation  Journal Articles
• Lack of Relationship Between Enhanced Bleeding Induced by Heparin and Other Sulfated Polysaccharides and Enhanced Catalysis of Thrombin Inhibition  Journal Articles
• Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trials  Journal Articles
• Left Atrial Appendage Closure after Ablation for Atrial Fibrillation.  Journal Articles
• Left Atrial Appendage Occlusion  Journal Articles
• Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials  Journal Articles
• Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia  Journal Articles
• Letter to the Editor  Journal Articles
• Life-threatening lingual artery hemorrhage after cardiac surgery  Journal Articles
• Limited Fibrin Specificity of Tissue-type Plasminogen Activator and Its Potential Link to Bleeding  Journal Articles
• Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial  Journal Articles
• Local venous infusion of streptokinase in DVT  Journal Articles
• Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants  Journal Articles
• Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials  Journal Articles
• Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction  Journal Articles
• Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis  Journal Articles
• Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation?  Conferences
• Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism  Journal Articles
• Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis  Journal Articles
• Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES  Journal Articles
• Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction  Journal Articles
• Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children  Journal Articles
• Long-term Clinical Outcomes of Splanchnic Vein Thrombosis  Journal Articles
• Long-term risk of adverse outcomes according to atrial fibrillation type  Journal Articles
• Long-term use of left ventricular assist devices: a report on clinical outcomes  Journal Articles
• Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference  Journal Articles
• Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement  Journal Articles
• Longitudinal Changes in Health‐Related Quality of Life in Patients With Atrial Fibrillation  Journal Articles
• Long‐term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients  Journal Articles
• Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism  Journal Articles
• Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery  Journal Articles
• Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism  Conferences
• Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate  Journal Articles
• Low PAI‐1 activity in relation to inflammatory parameters, insulin profile and body mass index  Journal Articles
• Low molecular weight heparin  Journal Articles
• Low molecular weight heparin and bleeding in patients with chronic renal failure  Journal Articles
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Journal Articles
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer  Journal Articles
• Low molecular weight heparin: a critical analysis of clinical trials.  Journal Articles
• Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism  Journal Articles
• Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial  Journal Articles
• Low-Intensity versus Conventional-Intensity Warfarin for Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism  Journal Articles
• Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months  Journal Articles
• Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism  Journal Articles
• Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients  Journal Articles
• Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer  Journal Articles
• Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial  Journal Articles
• Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery  Journal Articles
• Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review  Journal Articles
• Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials  Journal Articles
• Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial  Journal Articles
• Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants  Journal Articles
• Low-molecular-weight heparin in patients with chronic renal insufficiency  Journal Articles
• Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review  Journal Articles
• Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Journal Articles
• Lower-dose emicizumab prophylaxis: can less be more?  Journal Articles
• Magnitude of and Risk Factors for In-Hospital and Postdischarge Stroke in Patients With Acute Coronary Syndromes  Journal Articles
• Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin  Journal Articles
• Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials  Journal Articles
• Major bleeding risk with warfarin for deep vein thrombosis.  Journal Articles
• Management Of Venous Thromboembolism: Optimization By Clinical Trials  Journal Articles
• Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin  Journal Articles
• Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting  Journal Articles
• Management of Anticoagulation before and after Elective Surgery  Journal Articles
• Management of Bleeding Complications in the Anticoagulated Patient  Journal Articles
• Management of Bleeding in Patients Receiving Conventional or New Anticoagulants  Journal Articles
• Management of Bleeding in Patients with Advanced Cancer  Journal Articles
• Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy  Journal Articles
• Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures  Journal Articles
• Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures  Journal Articles
• Management of bleeding complications in patients with cancer on DOACs  Journal Articles
• Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage  Journal Articles
• Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease  Journal Articles
• Management of bleeding with oral anticoagulants in patients with atrial fibrillation  Journal Articles
• Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis  Journal Articles
• Management of direct oral anticoagulant associated bleeding: Results of a multinational survey  Journal Articles
• Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses  Journal Articles
• Management of intentional overdose of low-molecular-weight heparin  Journal Articles
• Management of major bleeds in patients with immune thrombocytopenia  Journal Articles
• Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report  Journal Articles
• Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis  Journal Articles
• Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study  Journal Articles
• Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting  Journal Articles
• Managing Oral Anticoagulant Therapy  Journal Articles
• Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents  Conferences
• Managing oral anticoagulant therapy.  Journal Articles
• Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides  Journal Articles
• Marijuana Use  Journal Articles
• Massive hemorrhage protocol survey: Marked variability and absent in one-third of hospitals in Ontario, Canada  Journal Articles
• Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study  Journal Articles
• Measuring Dabigatran Levels: What Tests Are Available and What Still Needs to Be Done?  Journal Articles
• Mechanical valves  Journal Articles
• Mechanical versus bioprosthetic valves in chronic dialysis: a systematic review and meta-analysis  Journal Articles
• Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency  Journal Articles
• Meta-analysis of minimalist versus standard care approach for transcatheter aortic valve replacement.  Journal Articles
• Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients  Journal Articles
• Meta‐Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study  Journal Articles
• Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies  Journal Articles
• Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers  Journal Articles
• Methods of Administering Superimposed High-Frequency Jet Ventilation and the Associated Risk for Aspiration in a Model of Tracheal Bleeding  Journal Articles
• Miconazole Oral Gel Potentiates Warfarin Anticoagulant Activity  Journal Articles
• Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.  Journal Articles
• Minimizing costs for treating deep vein thrombosis: the role for fondaparinux  Journal Articles
• Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS ₂ and CHA ₂ DS ₂ -VASc Scores in Patients With Atrial Fibrillation  Journal Articles
• Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1 frameshift mutation  Journal Articles
• Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent  Journal Articles
• Monoclonal Purified F VIII for Continuous Infusion: Stability, Microbiological Safety and Clinical Experience  Journal Articles
• More on Acutely Injured Patients Receiving Dabigatran  Journal Articles
• Morphological abnormalities during early-life development of the estuarine mummichog, Fundulus heteroclitus, as an indicator of androgenic and anti-androgenic endocrine disruption  Journal Articles
• Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction  Journal Articles
• Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials  Journal Articles
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Journal Articles
• Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings  Journal Articles
• Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia  Journal Articles
• Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation  Journal Articles
• Mutation Analysis in F9 Gene of 17 Families with Haemophilia B from Iran  Conferences
• Myocardial injury after non-cardiac surgery: diagnosis and management  Journal Articles
• Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable  Journal Articles
• Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™  Journal Articles
• Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy  Journal Articles
• Neutralization of Enoxaparine-lnduced Bleeding by Protamine Sulfate  Journal Articles
• New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management  Conferences
• New Strategies for the Optimal Use of Platelet Transfusions  Journal Articles
• New anticoagulants: Moving beyond the direct oral anticoagulants  Journal Articles
• New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF  Journal Articles
• New oral anticoagulant agents – general features and outcomes in subsets of patients  Journal Articles
• New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty  Journal Articles
• New oral anticoagulants in development  Journal Articles
• Newly Identified Events in the RE-LY Trial  Journal Articles
• Ninety‐Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Stroke  Journal Articles
• Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats  Journal Articles
• Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B  Journal Articles
• Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke  Journal Articles
• Noninvasive Diagnosis of Pulmonary Hemorrhage in Rheumatoid Arthritis  Journal Articles
• Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment  Journal Articles
• North American Thrombosis Forum, AF Action Initiative Consensus Document  Journal Articles
• Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study  Journal Articles
• Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants  Journal Articles
• Novel oral anticoagulants and reversal agents: Considerations for clinical development  Journal Articles
• ON THE BLEEDER: A CASE OF VON WILLEBRAND'S DISEASE AND ITS TREATMENT WITH HUMAN ANTI-HAEMOPHILIC FACTOR.  Journal Articles
• ON THE BLEEDER: A CASE OF VON WILLEBRAND'S DISEASE AND ITS TREATMENT WITH HUMAN ANTI‐HÆMOPHILIC FACTOR  Journal Articles
• Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report)  Journal Articles
• One-year Outcomes after Discharge from Noncardiac Surgery and Association between Predischarge Complications and Death after Discharge: Analysis of the VISION Prospective Cohort Study  Journal Articles
• On‐demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome  Journal Articles
• Optimal Duration of Anticoagulant Therapy  Journal Articles
• Optimal Duration of Oral Anticoagulant Therapy in Venous Thromboembolism  Journal Articles
• Optimal intensity and monitoring warfarin  Journal Articles
• Optimal reversal of vitamin K antagonists  Journal Articles
• Oral Anticoagulant Use and Post-Fall Mortality in Long-Term Care Home Residents.  Journal Articles
• Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease  Journal Articles
• Oral Anticoagulation Treatment in the Elderly  Journal Articles
• Oral Apixaban for the Treatment of Acute Venous Thromboembolism  Journal Articles
• Oral Corticosteroid Therapy as an Adjuvant Treatment for Acute Bleeding in Hemophilia Patients With High Titer Inhibitors  Journal Articles
• Oral Rivaroxaban for Symptomatic Venous Thromboembolism  Journal Articles
• Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism  Journal Articles
• Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin  Journal Articles
• Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives  Journal Articles
• Oral anticoagulants in patients with coronary artery disease  Journal Articles
• Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks  Journal Articles
• Oral anticoagulation for prolonging survival in patients with cancer  Journal Articles
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Oral anticoagulation in venous thromboembolism: decisions based on more than mere feelings  Journal Articles
• Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial  Journal Articles
• Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis  Journal Articles
• Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement  Journal Articles
• Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS).  Journal Articles
• Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10  Journal Articles
• Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials  Journal Articles
• Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study  Journal Articles
• Outcomes and predictors of very stable INR control during chronic anticoagulation therapy  Journal Articles
• Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study  Journal Articles
• Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders  Journal Articles
• Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF  Journal Articles
• Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin  Journal Articles
• Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study  Journal Articles
• Overview of the clinical results of pentasaccharide in major orthopedic surgery.  Journal Articles
• Palliative Management of Bleeding Events in Advanced Cancer Patients  Journal Articles
• Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation  Journal Articles
• Parenteral anticoagulation in ambulatory patients with cancer  Journal Articles
• Parenteral anticoagulation in ambulatory patients with cancer  Journal Articles
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation  Journal Articles
• Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study  Journal Articles
• Past meets present: Reviving 80‐year‐old Canadian dried serum from World War II and its significance in advancing modern freeze‐dried plasma for prehospital management of haemorrhage  Journal Articles
• Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort  Journal Articles
• Patient data meta‐analysis of Post‐Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated with rAHF‐PFM  Journal Articles
• Patient outcomes using the European label for dabigatran  Journal Articles
• Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment  Journal Articles
• Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry  Journal Articles
• Patients with Peripheral Artery Disease in the COMPASS Trial  Journal Articles
• Patterns of joint damage in severe haemophilia A treated with prophylaxis  Journal Articles
• Patterns of tertiary prophylaxis in Canadian adults with severe and moderately severe haemophilia B  Journal Articles
• Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial  Journal Articles
• Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury  Journal Articles
• Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation  Journal Articles
• Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery  Journal Articles
• Perioperative Management of Dabigatran  Journal Articles
• Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants  Journal Articles
• Perioperative Management of the Direct Oral Anticoagulants  Journal Articles
• Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial  Journal Articles
• Perioperative management of antithrombotic therapy: a case-based narrative review  Journal Articles
• Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach  Journal Articles
• Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin  Journal Articles
• Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists  Journal Articles
• Periprocedural Management of Oral Anticoagulation  Journal Articles
• Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants  Journal Articles
• Periprocedural anticoagulation practices in warfarin-treated patients who require elective angiography with or without percutaneous coronary intervention: A retrospective chart review  Journal Articles
• Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH  Journal Articles
• Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy  Journal Articles
• Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer  Journal Articles
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Journal Articles
• Periprocedural risk of bleeding and thrombosis: to bridge or not to bridge. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 2  Journal Articles
• Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH  Journal Articles
• Pharmacologic tools to reduce bleeding in surgery.  Journal Articles
• Pharmacological Actions of Sulodexide  Journal Articles
• Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis  Journal Articles
• Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial  Journal Articles
• Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome  Journal Articles
• Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.  Journal Articles
• Plasma and Plasma Protein Product Transfusion: A Canadian Blood Services Centre for Innovation Symposium  Journal Articles
• Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities  Journal Articles
• Plasma transfusion practices: A multicentre electronic audit  Journal Articles
• Plasma transfusion trials and tribulations  Journal Articles
• Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry  Journal Articles
• Platelet Transfusion: A Clinical Practice Guideline From the AABB  Journal Articles
• Platelet count or bleeding as the outcome in ITP trials?  Journal Articles
• Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation  Journal Articles
• Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function  Journal Articles
• Point-of-Care Hemostatic Testing in Cardiac Surgery  Journal Articles
• Positioning new treatments in the management of immune thrombocytopenia  Journal Articles
• Possible Influence of Stroke Etiology on Hemorrhagic Transformation Following Thrombolysis in Warfarin-Treated Patients  Journal Articles
• Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients  Journal Articles
• Potential antidotes for reversal of old and new oral anticoagulants  Journal Articles
• Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation  Journal Articles
• Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk  Journal Articles
• Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure  Conferences
• Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban  Journal Articles
• Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants  Journal Articles
• Practical management of coagulopathy associated with warfarin  Journal Articles
• Practical management of coagulopathy associated with warfarin.  Journal Articles
• Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung  Journal Articles
• Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism  Journal Articles
• Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment  Journal Articles
• Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol  Journal Articles
• Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE: results of the XALIA study  Journal Articles
• Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study  Journal Articles
• Predictors of Mortality in Patients With Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial  Journal Articles
• Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review  Journal Articles
• Prehospital Freeze-Dried Plasma in Trauma: A Critical Review  Journal Articles
• Prenatal Diagnosis of Genetic Disorders: Trials and Tribulations  Journal Articles
• Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study  Journal Articles
• Preperitoneal packing for pelvic fracture-associated hemorrhage: A systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma  Journal Articles
• Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model  Journal Articles
• Prevalence and outcomes of type 2 myocardial infarction in patients with cancer: A retrospective analysis from the National Inpatient Sample dataset  Journal Articles
• Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registries  Journal Articles
• Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran  Journal Articles
• Preventing and managing bleeding complications in anticoagulated patients: A case based approach  Journal Articles
• Prevention and 18-Month Outcomes of Serious Pulmonary Hemorrhage in Extremely Low Birth Weight Infants: Results From the Trial of Indomethacin Prophylaxis in Preterms  Journal Articles
• Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention  Journal Articles
• Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment  Journal Articles
• Prevention of Deep Vein Thrombosis after Elective Hip Surgery  Journal Articles
• Prevention of Postthrombotic Syndrome  Journal Articles
• Prevention of VTE in Orthopedic Surgery Patients  Journal Articles
• Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial  Journal Articles
• Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation  Journal Articles
• Prevention of venous thrombosis with small, subcutaneous doses of heparin  Journal Articles
• Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized  Journal Articles
• Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”  Journal Articles
• Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation  Journal Articles
• Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation  Journal Articles
• Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis  Journal Articles
• Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran  Journal Articles
• Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials  Journal Articles
• Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation  Journal Articles
• Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation  Journal Articles
• Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature  Journal Articles
• Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation  Journal Articles
• Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery.  Journal Articles
• Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis  Journal Articles
• Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy  Journal Articles
• Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multicentre trial)  Journal Articles
• Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry  Journal Articles
• Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study  Journal Articles
• Quality of oral anticoagulant control and treatment in Sweden  Journal Articles
• Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study Group.  Journal Articles
• Quantitative Susceptibility Mapping for Characterization of Intraplaque Hemorrhage and Calcification in Carotid Atherosclerotic Disease  Journal Articles
• Quebec Platelet Disorder: Update on Pathogenesis, Diagnosis, and Treatment  Journal Articles
• Quebec platelet disorder  Journal Articles
• RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT  Journal Articles
• RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate  Journal Articles
• RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome  Journal Articles
• Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease  Journal Articles
• Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial  Journal Articles
• Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials  Journal Articles
• Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation  Journal Articles
• Randomized Trial of Compression Duration After Transradial Cardiac Catheterization and Intervention  Journal Articles
• Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis  Journal Articles
• Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention  Journal Articles
• Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients  Journal Articles
• Rare bleeding disorders: Advances in management  Journal Articles
• Rates of hemorrhage during warfarin therapy for atrial fibrillation  Journal Articles
• Rationale Behind the Development of Low Molecular Weight Heparin Derivatives  Journal Articles
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Journal Articles
• Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery  Journal Articles
• Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention  Journal Articles
• Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens  Journal Articles
• Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis  Journal Articles
• Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS  Journal Articles
• Real‐world variability in dabigatran levels in patients with atrial fibrillation  Journal Articles
• Reanimating Patients After Traumatic Cardiac Arrest  Journal Articles
• Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent  Journal Articles
• Recombinant FVIIa in children with liver disease  Journal Articles
• Recombinant Factor VIIa in Multiple Surgery  Journal Articles
• Recombinant activated factor VII for the treatment of life-threatening haemorrhage  Journal Articles
• Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors  Journal Articles
• Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH  Journal Articles
• Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference  Journal Articles
• Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?  Journal Articles
• Recurrent fetomaternal transfusion in two consecutive pregnancies  Journal Articles
• Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis  Journal Articles
• Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial  Journal Articles
• Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial  Journal Articles
• Reduced‐dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta‐analysis—Response to Commentary  Journal Articles
• Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis  Journal Articles
• Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin  Journal Articles
• Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins  Journal Articles
• Refining Risk Prediction for Recurrent Venous Thromboembolism: Can We Do Better?  Journal Articles
• Relation of Extracardiac Vascular Disease and Outcomes in Patients With Diabetes (1.1 Million) Hospitalized for Acute Myocardial Infarction  Journal Articles
• Relationship Between Dose, Anticoagulant Effect and the Clinical Efficacy and Safety of Heparin  Conferences
• Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes  Journal Articles
• Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin  Journal Articles
• Relationships between factor VIII:Ag and factor VIII in recombinant and plasma‐derived factor VIII concentrates  Journal Articles
• Renal function and outcomes in acute coronary syndrome: impact of clopidogrel  Journal Articles
• Repair of congenital diaphragmatic hernia after weaning from extracorporeal membrane oxygenation  Conferences
• Reply: regarding the effect of dabigatran plasma concentrations.  Journal Articles
• Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study  Journal Articles
• Response to Letter Regarding Article, “Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin”  Journal Articles
• Response to Letters Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”  Journal Articles
• Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.  Journal Articles
• Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients  Journal Articles
• Restarting Anticoagulation After Major Bleeding in Patients With Atrial Fibrillation  Journal Articles
• Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE Trial  Journal Articles
• Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality  Journal Articles
• Retroperitoneal Hemorrhage After a Vaginal Mesh Prolapse Procedure  Journal Articles
• Reversal agents for current and forthcoming direct oral anticoagulants  Journal Articles
• Reversal agents for non-vitamin K antagonist oral anticoagulants  Journal Articles
• Reversal of Direct Oral Anticoagulants: Current Status and Future Directions  Journal Articles
• Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study  Journal Articles
• Reversal of direct oral anticoagulants: a practical approach  Journal Articles
• Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH  Journal Articles
• Reversal of target-specific oral anticoagulants  Journal Articles
• Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice  Journal Articles
• Reversing Anticoagulant Therapy  Journal Articles
• Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants  Journal Articles
• Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan　― Insights From GARFIELD-AF ―  Journal Articles
• Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit)  Journal Articles
• Risk and complications of venous thromboembolism in dialysis patients  Journal Articles
• Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis  Journal Articles
• Risk factors for MACE and bleeding in atrial fibrillation patients undergoing surgery: Insights from the bridge trial  Journal Articles
• Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature  Journal Articles
• Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation  Journal Articles
• Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment  Journal Articles
• Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation  Journal Articles
• Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants  Journal Articles
• Risk of Haemorrhage Associated with Long Term Anticoagulant Therapy  Journal Articles
• Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants  Journal Articles
• Risk of Stent Thrombosis and Major Bleeding with Bivalirudin Compared with Active Control: A Systematic Review and Meta-analysis of Randomized Trials  Journal Articles
• Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal  Journal Articles
• Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trials  Journal Articles
• Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism  Journal Articles
• Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage  Journal Articles
• Risk stratification of acute pulmonary embolism  Journal Articles
• Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews  Journal Articles
• Risks and Benefits of Anticoagulant Therapy  Journal Articles
• Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial  Journal Articles
• Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD  Journal Articles
• Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction  Journal Articles
• Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease  Journal Articles
• Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial  Journal Articles
• Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions  Journal Articles
• Rivaroxaban for Patients with Intermittent Claudication.  Journal Articles
• Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial  Journal Articles
• Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source  Journal Articles
• Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness  Journal Articles
• Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer  Journal Articles
• Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies  Journal Articles
• Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation  Journal Articles
• Rivaroxaban in Peripheral Artery Disease after Revascularization  Journal Articles
• Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation  Journal Articles
• Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits  Journal Articles
• Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism  Journal Articles
• Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers  Journal Articles
• Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial  Journal Articles
• Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study  Journal Articles
• Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease  Journal Articles
• Rivaroxaban with or without aspirin for prevention of cardiovascular disease  Journal Articles
• Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial  Journal Articles
• Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial  Journal Articles
• Role of aspirin for prevention and treatment of perioperative cardiovascular events  Journal Articles
• Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients  Journal Articles
• Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures  Journal Articles
• Rupture of an aneurysm of the splenic artery: an unusual cause of massive gastric hemmorrhage.  Journal Articles
• Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study  Journal Articles
• Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)  Journal Articles
• Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial  Journal Articles
• Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting  Journal Articles
• Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study.  Journal Articles
• Safety of lumbar punctures in patients with thrombocytopenia  Journal Articles
• Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists  Journal Articles
• Safety of thrombolysis in cerebral venous thrombosis  Journal Articles
• Safety of thrombolysis in cerebral venous thrombosis A systematic review of the literature  Journal Articles
• Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk  Journal Articles
• Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19  Journal Articles
• Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran  Journal Articles
• Secondary prevention of venous thromboembolism  Journal Articles
• Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis  Journal Articles
• Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer  Journal Articles
• Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE  Journal Articles
• Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review  Journal Articles
• Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: reply  Journal Articles
• Severe maternal morbidity surveillance, temporal trends and regional variation: A population‐based cohort study  Journal Articles
• Sex-specific differences in adverse outcome events among patients with atrial fibrillation  Journal Articles
• Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD  Journal Articles
• Shared Decision Making in the Management of Children With Newly Diagnosed Immune Thrombocytopenia  Journal Articles
• Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen?  Journal Articles
• Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial  Journal Articles
• Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation  Journal Articles
• Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study  Journal Articles
• Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the NuProtect study  Journal Articles
• Single Bolus r-SAK Before Primary PCI for ST-Segment–Elevation Myocardial Infarction  Journal Articles
• Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction  Journal Articles
• Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study  Journal Articles
• Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective  Journal Articles
• Specific antidotes for bleeding associated with direct oral anticoagulants  Journal Articles
• Spotlight on animal models of acute traumatic coagulopathy: an update  Journal Articles
• Standardized Bleeding Definitions for Cardiovascular Clinical Trials  Journal Articles
• Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group  Journal Articles
• State of the Art-A Journey through the World of Antithrombotic Therapy  Journal Articles
• Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves  Journal Articles
• Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update  Journal Articles
• Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial  Journal Articles
• Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease  Journal Articles
• Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey  Journal Articles
• Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation  Journal Articles
• Stroke prevention in atrial fibrillation: Closing the gap  Journal Articles
• Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry  Journal Articles
• Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program  Journal Articles
• Studies on the medical treatment of deep vein thrombosis.  Journal Articles
• Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis  Journal Articles
• Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial  Journal Articles
• Sub‐segmental pulmonary embolism in three academic teaching hospitals: a review of management and outcomes  Journal Articles
• Suggestions for the management of factor VIII inhibitors  Journal Articles
• Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials  Journal Articles
• Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis  Journal Articles
• Susceptibility weighted imaging in detecting hemorrhage in acute cervical spinal cord injury  Journal Articles
• Switching from standard to extended half‐life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics  Journal Articles
• Switching patients in the age of long-acting recombinant products?  Journal Articles
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Journal Articles
• Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants  Journal Articles
• Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper-Gastrointestinal and Hepatopancreatobiliary Surgery  Journal Articles
• Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer  Journal Articles
• Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis  Journal Articles
• Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism  Journal Articles
• Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology  Journal Articles
• Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology  Journal Articles
• THROMBOLYTIC THERAPY FOR VENOUS THROMBOEMBOLISM  Journal Articles
• Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates  Journal Articles
• Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes  Journal Articles
• The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation  Journal Articles
• The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA‐Associated Vasculitis  Journal Articles
• The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?  Journal Articles
• The Coagulation System in Humans  Journal Articles
• The Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation  Journal Articles
• The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism  Journal Articles
• The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients  Journal Articles
• The Efficacy and Safety of Heparin in Patients With Sepsis  Journal Articles
• The Efficacy of Leukodepletion to Improve Platelet Transfusion Response: A Critical Appraisal of Clinical Studies  Journal Articles
• The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis  Journal Articles
• The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations  Journal Articles
• The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation  Journal Articles
• The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology  Journal Articles
• The Impact of Uncross-Matched Blood Transfusion on the Need for Massive Transfusion and Mortality: Analysis of 5,166 Uncross-Matched Units  Journal Articles
• The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin<subtitle>A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty</subtitle>  Conferences
• The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis  Conferences
• The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study  Journal Articles
• The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE  Journal Articles
• The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale  Journal Articles
• The Pharmacology and Management of the Vitamin K Antagonists  Journal Articles
• The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism  Journal Articles
• The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy  Journal Articles
• The Risk of Major Hemorrhage with CKD  Journal Articles
• The aspirin controversy in primary prevention  Journal Articles
• The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism  Journal Articles
• The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events  Journal Articles
• The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation  Journal Articles
• The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model  Journal Articles
• The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions  Journal Articles
• The clinical impact of bleeding during oral anticoagulant therapy  Journal Articles
• The diagnosis and prevention of post operative venous thrombosis.  Journal Articles
• The direct thrombin inhibitor hirudin  Journal Articles
• The effect of aspirin on the size of the hemostatic plug  Journal Articles
• The effects of rivaroxaban on the complications of surgery after total hip or knee replacement  Journal Articles
• The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study  Journal Articles
• The evolving treatment of peripheral arterial disease: preventing ischaemic events in the post-COMPASS era  Journal Articles
• The fibrinogen but not the Factor VIII content of transfused plasma determines its effectiveness at reducing bleeding in coagulopathic mice  Journal Articles
• The haemorrhagic and antithrombotic effects of dermatan sulphate  Journal Articles
• The haemorrhagic and antithrombotic effects of dermatan sulphate.  Journal Articles
• The historical origins of modern international normalized ratio targets  Journal Articles
• The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis  Journal Articles
• The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial  Journal Articles
• The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review  Journal Articles
• The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians  Journal Articles
• The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study  Journal Articles
• The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients  Journal Articles
• The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study  Journal Articles
• The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin.  Journal Articles
• The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits  Journal Articles
• The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.  Journal Articles
• The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.  Journal Articles
• The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality  Journal Articles
• The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism  Journal Articles
• The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia  Journal Articles
• The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial  Journal Articles
• The safety of fondaparinux for the prevention and treatment of venous thromboembolism  Journal Articles
• The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants  Journal Articles
• The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta‐analysis of a diagnostic test  Journal Articles
• The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: Influence of dosage regimens in rabrits  Journal Articles
• The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive value  Journal Articles
• The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease.  Journal Articles
• Theoretical and Practical Aspects of Thrombolytic Therapy  Journal Articles
• Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19  Journal Articles
• Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19  Journal Articles
• Therapeutic strategies for thrombosis: new targets and approaches  Journal Articles
• Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature  Journal Articles
• Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])  Journal Articles
• Thromboembolic Complications in Pediatric Hematologic Malignancies  Journal Articles
• Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy  Journal Articles
• Thromboembolism in children with sarcoma  Journal Articles
• Thromboembolism prevention in ischaemic stroke  Journal Articles
• Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism  Journal Articles
• Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.  Journal Articles
• Thrombolytic Therapy for Submassive Pulmonary Embolism?  Journal Articles
• Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial  Journal Articles
• Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: a network meta-analysis  Journal Articles
• Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials  Journal Articles
• Thrombosis and anticoagulation in the setting of renal or liver disease  Journal Articles
• Thrombosis and hemorrhage experienced by hospitalized children with SARS‐CoV‐2 infection or MIS‐C: Results of the PICNIC registry  Journal Articles
• Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial  Journal Articles
• Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study  Journal Articles
• Time to rethink clinically important outcomes in platelet transfusion trials  Journal Articles
• Tossing a coin or using common sense  Journal Articles
• Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial  Journal Articles
• Tourniquet use for peripheral vascular injuries in the civilian setting  Journal Articles
• Tracheostomy in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Single-Center Experience  Journal Articles
• Tranexamic Acid in Patients Undergoing Noncardiac Surgery  Journal Articles
• Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial  Journal Articles
• Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.  Journal Articles
• Transfusion Challenges in Patients with Hematological Malignancies in Sub-Saharan Africa: A Prospective Observational Study from the Uganda Cancer Institute  Journal Articles
• Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using ‘Adapted ADAPTE’  Journal Articles
• Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine  Journal Articles
• Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding  Journal Articles
• Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies  Journal Articles
• Treatment and prevention of acute bleedings in von Willebrand disease – efficacy and safety of Wilate^®, a new generation von Willebrand factor/factor VIII concentrate  Journal Articles
• Treatment of Acute Coronary Syndromes  Journal Articles
• Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis  Journal Articles
• Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction  Journal Articles
• Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review.  Journal Articles
• Treatment of Venous Thromboembolism in Cancer Patients  Journal Articles
• Treatment of Venous Thrombosis in the Cancer Patient  Journal Articles
• Treatment of Warfarin-Associated Coagulopathy  Journal Articles
• Treatment of acute ischemic stroke: from fibrinolysis to neurointervention  Journal Articles
• Treatment of bleeding complications in patients on anticoagulant therapy  Journal Articles
• Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms  Journal Articles
• Treatment of critical bleeding events in patients with immune thrombocytopenia: a protocol for a systematic review and meta-analysis  Journal Articles
• Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis  Journal Articles
• Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study  Journal Articles
• Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial  Journal Articles
• Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer  Journal Articles
• Treatment with novel oral anticoagulants  Journal Articles
• Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI  Journal Articles
• Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users  Journal Articles
• Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism  Journal Articles
• Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF  Journal Articles
• Ulnar neuropathy resulting from diffuse intramuscular hemorrhage: A case report  Journal Articles
• Ultrasound guidance for transfemoral access in coronary procedures: an individual participant-level data metaanalysis from the femoral ultrasound trialist collaboration  Journal Articles
• Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis From the FAUST and UNIVERSAL Trials  Journal Articles
• Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial  Journal Articles
• Unanswered questions in venous thromboembolism  Journal Articles
• Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis  Journal Articles
• Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels  Journal Articles
• Unilateral suprarenal hemorrhage in a teenager: A case of TAFRO  Journal Articles
• Unresolved issues in the use of direct acting oral anticoagulants  Journal Articles
• Update on diagnostic testing for platelet function disorders: What is practical and useful?  Journal Articles
• Update on heparin: what do we need to know?  Journal Articles
• Uremic bleeding: Pathophysiology and clinical risk factors  Journal Articles
• Urgent Need to Measure Effects of Direct Oral Anticoagulants  Journal Articles
• Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial  Journal Articles
• Use of Antithrombotic Agents During Pregnancy  Journal Articles
• Use of antithrombotic agents during pregnancy.  Journal Articles
• Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients  Journal Articles
• Use of plasminogen activators in venous thrombosis  Journal Articles
• Use of warfarin (coumarin).  Journal Articles
• Using bevacizumab to treat metastatic cancer: UK consensus guidelines  Journal Articles
• Using low molecular weight heparin in special patient populations  Journal Articles
• Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort Study  Journal Articles
• Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses  Journal Articles
• Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia  Journal Articles
• Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC  Journal Articles
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Journal Articles
• Variability in platelet dense granule adenosine triphosphate release findings amongst patients tested multiple times as part of an assessment for a bleeding disorder  Journal Articles
• Variation in bleeding risk estimates among online calculators  Journal Articles
• Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation  Journal Articles
• Venous Thromboembolism in Older Adults: A Community-based Study  Journal Articles
• Venous limb gangrene and fatal hemorrhage: Adverse consequences of hit “overdiagnosis” in a patient with antiphospholipid syndrome  Journal Articles
• Venous thromboembolism and bleeding in a community setting  Journal Articles
• Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors  Journal Articles
• Venous thromboembolism in the elderly  Journal Articles
• Vitamin K antagonist reversal strategies: Systematic review and network meta‐analysis from the AABB  Journal Articles
• Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study  Journal Articles
• Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis  Journal Articles
• Vitamin K in anticoagulation therapy  Journal Articles
• Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10  Journal Articles
• Von Willebrand Disease: Gaining a global perspective  Journal Articles
• Vorapaxar in the Secondary Prevention of Atherothrombotic Events  Journal Articles
• Warfarin After Bioprosthetic Aortic Valve Implantation  Journal Articles
• Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios  Journal Articles
• Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis  Journal Articles
• Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial  Journal Articles
• Warfarin and Aspirin after Heart-Valve Replacement  Journal Articles
• Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm  Journal Articles
• Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis  Journal Articles
• Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences.  Journal Articles
• Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery  Journal Articles
• What can ex vivo experiments contribute to clinical haemostasis management?  Journal Articles
• What's the Incidence of Delayed Splenic Bleeding in Children After Blunt Trauma? An Institutional Experience and Review of the Literature  Journal Articles
• When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH  Journal Articles
• When guidelines collide  Journal Articles
• When is it safe to stop for safety?  Journal Articles
• Why Is Factor Xa Not a Better Target Than Factor IIa for Therapeutic Inhibition of Coagulation?  Journal Articles
• Will prasugrel supersede clopidogrel for acute coronary syndromes?  Journal Articles
• World bleeding disorders registry: The pilot study  Journal Articles
• Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation?  Journal Articles
• [Antithrombotic treatment of atrial fibrillation].  Journal Articles
• [Difficulties in obtaining financial support for studies of hemorrhage during treatment with anticoagulants].  Journal Articles
• [Elimination of antibodies against coagulation factor VIII: Factor VIIa is the most promising therapeutic alternative].  Journal Articles
• [One case of concurrent hemorrhage after pancreatic islet transplantation by percutaneous transhepatic portal approach].  Journal Articles
• [Prothromplex in stead of Beriplex P/N as acute antidote against warfarin].  Journal Articles
• [Use of parenteral anticoagulants in patients with coronary syndrome].  Journal Articles
• von Willebrand Factor: Form for Function  Journal Articles
• von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis  Journal Articles
• Ácido tranexâmico no tratamento da hemorragia no trauma  Journal Articles